Study of a blood product for trauma-related bleeding
Part of Blood & lymphatic, Genetic & congenital, Injuries & trauma clinical trials.
This trial tests a treatment called INTERCEPT Fibrinogen Complex (IFC) to help control bleeding in trauma patients. It is given to patients who arrive at the hospital quickly after injury and have low fibrinogen levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a traumatic injury.
- You are at least 18 years old, or if your age is unknown, you weigh about 110 pounds or more.
- You arrive at a participating trauma center within 1 hour of your injury.
- You have low levels of a clotting protein called fibrinogen when a quick test is done at the hospital.
- You have severe bleeding (hemorrhagic shock) that requires a blood transfusion and activation of the hospital's massive transfusion protocol.
- Your doctor decides that IFC treatment is needed and available at the time of enrollment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial studies whether giving antithrombin can better prevent harmful blood clots (venous thromboembolism) after serious injuries. The goal is to reduce clot risk while you’re in the trauma ICU or step-down unit.
This trial tests giving a blood clotting medicine called fibrinogen to adults with severe bleeding from trauma before they reach the hospital. The goal is to see if it helps control bleeding and improve outcomes.
This Phase 3 study tests whether giving fibrinogen early can improve outcomes for adults with serious trauma who are actively bleeding. The goal is to help blood clotting work better sooner and potentially reduce complications from uncontrolled bleeding.
This trial checks if a fast bedside test for fibrinogen (a protein that helps blood clot) can help guide treatment for trauma patients who are actively bleeding. It may lead to better care in the emergency department.
This trial tests whether giving fresh frozen plasma (a blood product) soon after a traumatic brain injury can help people recover better. It is for adults aged 18 to 65 with moderate to severe TBI confirmed by CT scan.
This trial compares two types of blood tests (a new quick test vs. standard tests) to see which helps doctors better manage bleeding after a severe injury. It is for adults with serious trauma who may have a blood clotting problem.
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.